MTPC Aims to Reach Midterm Targets through Royalties from Licensed Products, But Success Likely to Depend on Performance in Domestic Market

Mitsubishi Tanabe Pharma Corporation (MTPC) reached the halfway point of its midterm management plan for 2011-2015 at the end of September. In a meeting with reporters on August 30, President Michihiro Tsuchiya stressed that business has grown steadily up to...read more